Impel Pharmaceuticals Inc.
Impel Pharmaceuticals Inc. (IMPL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IMPL · as of Jun 9, 2026
Key Statistics
Explore Impel Pharmaceuticals Inc. Data
impl stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 66.7%
Competitors & Peers
impl competitorsIMPL
ACOR
AXDX
BLCM
CWBR
CYTOStock Performance
Full HistoryAbout Impel Pharmaceuticals Inc.
Impel Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical firm, concentrating its efforts on creating and commercializing therapies for individuals in the United States who are affec…
what is impel pharmaceuticals inc. · impl stock overview · impel pharmaceuticals inc. company profile · who is impel pharmaceuticals inc. ceo · impl NASDAQ · impel pharmaceuticals inc. headquarters · impel pharmaceuticals inc. business segments
About Stock Overview & Key Data
Impel Pharmaceuticals Inc. (IMPL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 23, 2021. As of the latest trading session, IMPL stock price is $0.04, with a market capitalization of $956,000. The stock has returned -98.88% over the past 12 months and -57.89% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Impel Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Impel Pharmaceuticals Inc. reported revenue of $12.7M and net income of -$129.4M. For detailed data — including Impel Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Impel Pharmaceuticals Inc. (IMPL) stock price is $0.04. The stock is traded on NASDAQ under the ticker symbol IMPL. The 52-week range is $0.02 – $4.20.